Tech Center 1600 • Art Units: 1653
This examiner grants 53% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17770281 | COMPOSITIONS AND METHODS FOR ENHANCING DIFFERENTIATION OF STEM CELL-DERIVED BETA CELLS | Final Rejection | President and Fellows of Harvard College |
| 18059135 | COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME | Final Rejection | Halozyme, Inc. |
| 18255307 | AMNIOTIC MEMBRANE FOR MYOCARDIAL REPAIR | Non-Final OA | The Regents of the University of California |
| 17778393 | CULTURES OF AND METHODS OF MANUFACTURING SQUAMOUS CELL CARCINOMA CELLS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 16604979 | CHITINASE ADMINISTRATION TO THE AIRWAY TO TREAT INFLAMMATION AND AGE-RELATED PULMONARY FIBROSIS | Non-Final OA | The Regents of the University of California |
| 17442489 | AMYLASE ENZYMES | Non-Final OA | BASF SE |
| 18241564 | LEAN PERFUSION CELL CULTURE METHODS | Non-Final OA | AMGEN INC. |
| 18575437 | FLUID SHEAR STRESS FOR EX VIVO ACTIVATION OF IMMUNE EFFECTOR CELLS | Non-Final OA | Vanderbilt University |
| 16634076 | METHOD FOR ISOLATING EXTRACELLULAR VESICLE USING HYDROPHOBIC INTERACTION | Non-Final OA | POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION |
| 18063001 | Engineered 3D-Printed Artificial Axons | Final Rejection | Massachusetts Institute of Technology |
| 17440618 | CONTROL OF NITROGEN FIXATION IN RHIZOBIA THAT ASSOCIATE WITH CEREALS | Non-Final OA | Massachusetts Institute of Technology |
| 17906490 | SARS-COV2-SPECIFIC T CELL COMPOSITIONS AND THEIR USE IN TREATING AND PREVENTING CORONAVIRUS AND OTHER RESPIRATORY VIRUS INFECTIONS | Final Rejection | Baylor College of Medicine |
| 18700200 | GIANT ORGANELLES RECOVERY AND USE THEREOF | Non-Final OA | UNIVERSITÉ PARIS CITÉ |
| 14397657 | Methods and Compositions for Generating Pancreatic Progenitors and Functional Beta Cells from hPSCs | Final Rejection | University Health Network |
| 18568589 | PRE-EPICARDIAL CELLS AND USES THEREOF | Non-Final OA | The General Hospital Corporation |
| 17781279 | Nerve Xenografts and Related Methods | Final Rejection | The General Hospital Corporation |
| 18742024 | Methods of Detecting Bacteria in Urine | Final Rejection | IDEXX LABORATORIES, Inc. |
| 16906111 | DECELLULARIZED TISSUE | Non-Final OA | ADEKA CORPORATION |
| 16713772 | DECELLULARIZED TISSUE | Non-Final OA | ADEKA CORPORATION |
| 17394008 | MESENCHYMAL CELL-DERIVED EXOSOMES TO TREAT NEUROLOGICAL DISORDERS | Final Rejection | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
| 18926991 | SOFT TISSUE REPAIR ALLOGRAFTS AND METHODS FOR PREPARING SAME | Final Rejection | Musculoskeletal Transplant Foundation |
| 17761121 | PROLONGED FUNCTION OF LIVER ORGANOIDS BY 3D COCULTURING OF HEPATIC LINAGE CELLS AS AN IN VITRO MODEL FOR THE STUDY OF LIVER DISEASE | Final Rejection | THE TRUSTEES OF INDIANA UNIVERSITY |
| 17776164 | MATRICES FOR CELL CULTURE | Non-Final OA | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 17625665 | COMPOSITIONS AND METHODS FOR CLEARING TISSUE | Non-Final OA | The University of Hong Kong |
| 17761879 | Cell Culture Media Tablets and Methods of Manufacture | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 18582581 | IN SITU EXPANSION OF ENGINEERED DEVICES FOR REGENERATION | Non-Final OA | Trustees of Boston University |
| 18763509 | COMPOSITIONS AND METHODS FOR PRODUCING CLOSTRIDIAL COLLAGENASES | Non-Final OA | Endo Biologics Limited |
| 18762269 | GENERATION OF GLUCOSE-RESPONSIVE BETA CELLS | Non-Final OA | University of Copenhagen |
| 17426827 | Means and Methods to Overrule Glucose-Mediated Repression of Respiration in Yeast | Non-Final OA | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D |
| 17755275 | FIBROBLAST-DERIVED UNIVERSAL IMMUNOLOGICAL COMPOSITION | Final Rejection | FIGENE, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy